CEO Niccolo de Masi stated during a CNBC interview with Jim Cramer that the era of quantum supremacy, meaning when quantum ...

Novo Nordisk faces challenges in the competitive GLP-1 market, but its strong brand and R&D create opportunities for ...

Detailed price information for Quantum Biopharma Ltd (QNTM-Q) from The Globe and Mail including charting and trades.

Quantum BioPharma (NASDAQ: QNTM) , a biopharmaceutical company focused on neurodegenerative therapies, has purchased 2,000 shares of GameStop Corp. ( ...

A Sharp Decline in Quantum Hype Quantum computing, heralded as the next frontier in computational power, promises to ...

D-Wave Quantum faces challenges with episodic sales, limited recurring revenue, and ongoing dilution. Click here to read an ...

Investing.com -- Quantum BioPharma Ltd. (NASDAQ: QNTM) stock fell 5.7% after the company announced it purchased 2,000 shares ...

Biopharmaceutical company Quantum BioPharma said it has acquired 2,000 shares of specialty games and entertainment retailer GameStop in what it calls a strategic investment.

ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone ...

Quantum BioPharma (QNTM) announced the purchase of 2,000 shares of GameStop (GME) to hold on the Company’s balance sheet as a strategic ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to innovative therapies for ...

The ATM program comes as D-Wave’s Q1 2025 revenue surged 509% year-over-year, boosted by a major system sale to Germany’s ...